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Mutations in WNK kinases cause the human hyper-
tensive disease pseudohypoaldosteronism type II
(PHAII), but the regulatory mechanisms of the WNK
kinases are not well understood. Mutations in
kelch-like 3 (KLHL3) and Cullin3 were also recently
identified as causing PHAII. Therefore, new insights
into the mechanisms of human hypertension can be
gained by determining how these components
interact and how they are involved in the pathogen-
esis of PHAII. Here, we found that KLHL3 interacted
with Cullin3 and WNK4, induced WNK4 ubiquitina-
tion, and reduced the WNK4 protein level. The
reduced interaction of KLHL3 and WNK4 by PHAII-
causingmutations in either protein reduced the ubiq-
uitination of WNK4, resulting in an increased level of
WNK4 protein. Transgenic mice overexpressing
WNK4 showed PHAII phenotypes, andWNK4 protein
was indeed increased in Wnk4D561A/+ PHAII model
mice. Thus, WNK4 is a target for KLHL3-mediated
ubiquitination, and the impaired ubiquitination of
WNK4 is a common mechanism of human hereditary
hypertension.
INTRODUCTION
Hypertension is one of the biggest health problems in the indus-
trialized world because it damages critical organs. Studies of
monogenic hypertensive diseases, such as Liddle syndrome
(Shimkets et al., 1994) and pseudohypoaldosteronism type II
(PHAII) (Achard et al., 2001), have provided new insight into the
mechanisms of blood pressure regulation in humans. Liddle
syndrome is caused by mutations in the epithelial sodium
channel (ENaC) that increase the amount of ENaC in the apical
membranes of collecting ducts in the kidney through the
impairment of ENaC ubiquitination, thereby increasing sodium
reabsorption (Rossier and Schild, 2008). PHAII is another auto-
somal-dominant hereditary hypertensive disease that is charac-
terized by hyperkalemia and metabolic acidosis (Gordon, 1986),858 Cell Reports 3, 858–868, March 28, 2013 ª2013 The Authorsand genes encoding the WNK kinases (WNK1 and WNK4) were
identified in 2001 as responsible (Wilson et al., 2001). However,
the pathogenesis of PHAII was totally unknown when the WNK
genes were identified. Since then, numerous in vitro and in vivo
studies have been performed for clarifying the molecular patho-
genesis of PHAII (Bergaya et al., 2011; Lalioti et al., 2006; Liu
et al., 2011; McCormick and Ellison, 2011; Yang et al., 2003).
We generated a mouse model of PHAII carrying the same muta-
tion as patients with PHAII (Wnk4D561A/+ knockin mouse) (Yang
et al., 2007) and discovered that the constitutive activation of
a novel signal cascade, consisting of WNK kinases, OSR1 and
SPAK kinases, and the Na-Cl cotransporter (NCC), is the major
pathogenic mechanism of PHAII (Chiga et al., 2008, 2011).
However, the molecular pathogenesis of how the missense
mutation of WNK4 activates the cascade remains to be clarified.
Recently, two new genes (KLHL3 and Cullin3) were also iden-
tified as being associated with PHAII (Boyden et al., 2012; Louis-
Dit-Picard et al., 2012). However, how these genes are involved
in PHAII is unknown. Determining how these responsible genes
(WNK, KLHL3, and Cullin3) are orchestrated and how patho-
genic mutations in these genes cause a common hypertensive
disease will contribute to the understanding of the molecular
pathogenesis of human hypertension and also to the identifica-
tion of new targets for antihypertensive drugs.
The purpose of the present study was to determine the path-
ogenic role of PHAII-causing mutations in the WNK4, KLHL3,
and Cullin3 genes. We found that WNK4 kinase is a substrate
of KLHL3-Cullin3-targeted ubiquitination and that the PHAII-
causing mutations of WNK4 and KLHL3 resulted in impaired
WNK4 ubiquitination. The resultant increase in the WNK4 level
was confirmed in Wnk4D561A/+ PHAII model mice; this increase
constitutively activates the WNK-OSR1/SPAK-NCC signal
cascade and causes PHAII. Data from WNK4 transgenic mice
were consistent with this idea.
RESULTS
KLHL3 Interacted with and Regulated the Abundance
of WNK4 Kinase Protein
We have reported that the activation of the WNK-OSR1/SPAK-
NCC signal cascade is the major pathogenic mechanism of
PHAII caused by a WNK4 mutation (Yang et al., 2007), and
Figure 1. KLHL3 Was Coimmunoprecipitated with Cullin3 and WNK4
(A) FLAG-tagged Cullin3 (CUL3) was coimmunoprecipitated with Halo-tagged KLHL3 in HEK293T cells. IB, immunoblot; IP, immunoprecipitation.
(B) T7-tagged WNK4, OSR1, SPAK, and NCC were coexpressed with Halo-tagged KLHL3 in HEK293T cells and immunoprecipitated with T7 antibody. KLHL3
was coimmunoprecipitated only with WNK4. The asterisks indicate T7-tagged proteins.
(C) WNK4 was coimmunoprecipitated with endogenous Cullin3 in HEK293T cells in the presence of KLHL3 coexpression. Results similar to those shown in (A),
(B), and (C) were obtained in three separate experiments.mutations in the KLHL3 and Cullin3 genes were also reported
as causing the same PHAII phenotypes (Boyden et al., 2012;
Louis-Dit-Picard et al., 2012). These data suggest that
KLHL3 and Cullin3 may somehow interact with the compo-
nents of the WNK-OSR1/SPAK-NCC signal cascade. Because
KLHL proteins function as substrate adaptors in Cullin3-based
E3 ligase (Cirak et al., 2010; Kigoshi et al., 2011; Lee et al.,
2010; Lin et al., 2011), we first confirmed a complex formation
of KLHL3 and Cullin3 via coimmunoprecipitation (Figure 1A).
We then investigated whether KLHL3 interacted with the
components of the WNK-OSR1/SPAK-NCC signal cascade.
To verify this, we performed coimmunoprecipitation assays
of KLHL3 with WNK4, OSR1, SPAK, and NCC. As shown in
Figure 1B, KLHL3 was coimmunoprecipitated with WNK4,
but not with OSR1, SPAK, or NCC. The interaction of Cullin3
with WNK4 was also confirmed through coimmunoprecipita-
tion when KLHL3 was overexpressed (Figure 1C), consistent
with the previously reported role of KLHL proteins as substrate
adaptors in the Cullin3-based ubiquitin E3 ligase (Cirak et al.,
2010; Kigoshi et al., 2011; Lee et al., 2010; Lin et al., 2011).
We tried to demonstrate coimmunoprecipitation of endoge-
nous WNK4 and KLHL3 in kidney tissue and in cultured cells.
However, this was not successful due to the relatively low
level of expression of WNK4 in cultured cells and the lack of
KLHL3 antibodies adequate for immunoprecipitation. The
finding that WNK4 might be readily degraded by the bind-
ing to KLHL3 within cells as shown below also made the
detection of coimmunoprecipitation difficult, especially in
kidney samples.
To clarify the functional role of KLHL3 on WNK4, we overex-
pressed KLHL3 along with WNK4. As shown in Figure 2A,
KLHL3 overexpression dramatically decreased WNK4 protein
expression, even when overexpressed by a strong cytomegalo-
virus (CMV) promoter. The expression level of bacterial alkaline
phosphatase (BAP) driven by the same promoter was not
affected by KLHL3 coexpression. OSR1, SPAK, and NCCexpression levels were also not affected by KLHL3 coexpres-
sion (Figure 2B), supporting the results from the coimmunopre-
cipitation. To confirm the effect of KLHL3 on WNK4, we
evaluated this effect on the endogenous WNK4 in mpkDCT
cells, a mouse distal-tubule-derived cell line (Duong Van Huyen
et al., 2001) (Figure 2C). Wild-type KLHL3 significantly
decreased the endogenous WNK4 protein level. Conversely,
KLHL3 knockdown significantly increased the WNK4 protein
level (Figure 2D). Although these effects of KLHL3 expression
on WNK4 were observed without Cullin3 overexpression, we
further tested the effect of Cullin3 overexpression on WNK4 in
human embryonic kidney 293T (HEK293T) cells. As shown in
Figure 2E, coexpression of Cullin3 with KLHL3 further
decreased the WNK4 protein level compared with the expres-
sion of KLHL3 alone. Cullin3 alone did not affect WNK4 abun-
dance. These data suggested that the KLHL3-Cullin3 complex
might be a strong regulator of the WNK4 protein abundance
within cells. Although we tried to measure the half-life of
WNK4 in the presence of KLHL3 and Cullin3, the robust
decrease of WNK4 by KLHL3 and Cullin3 made the measure-
ment extremely difficult. The difference could be highly signifi-
cant based on the steady-state levels of transiently expressed
WNK4, as shown in Figures 2A and 2B.
Next, we evaluated how a PHAII-causing mutation (R528H) of
KLHL3 and Cullin3 affected the abundance of WNK4. When the
expression levels of wild-type and mutant KLHL3 were similar,
the R528H mutant was less able to reduce the endogenous
protein level of WNK4 as compared to wild-type KLHL3
(Figure 2C). The PHAII-causing mutations of the Cullin3 gene
were reported to cause skipping of exon 9, which codes the
segment (57 residues from 403–459) linking the BTB-binding
and RING-binding domains of Cullin3 (Boyden et al., 2012). To
investigate the pathogenic effect of the mutant Cullin3, we
prepared Cullin3 lacking this segment. As shown in Figure 2E,
the mutant Cullin3 was also less able to reduce WNK4 as
compared to wild-type Cullin3.Cell Reports 3, 858–868, March 28, 2013 ª2013 The Authors 859
Figure 2. Effect of Wild-Type and PHAII-Causing Mutant KLHL3 and Cullin3 Expression on Cellular WNK4 Abundance
(A) When coexpressed with KLHL3, the abundance of WNK4 protein within HEK293T cells expressed by CMV promoter (p33FLAG-CMV-10 vector, Sigma-
Aldrich) was dramatically decreased, whereas the abundance of BAP expressed by the same expression vector was not affected by KLHL3 coexpression.
(B) The reduction of WNK4 by KLHL3 coexpression was confirmed in another expression system ofWNK4 (pRK5 vector), and OSR1, SPAK, and NCC levels were
not affected by KLHL3 coexpression. Results similar to those shown in (A) and (B) were obtained in three separate experiments.
(C) Effect of wild-type and a PHAII-causingmutant (R528H) KLHL3 expression on the cellular abundance ofWNK4. EndogenousWNK4 level inmpkDCT cells was
decreased by wild-type KLHL3 expression. However, a similar level of the mutant KLHL3 expression failed to reduceWNK4 (*p < 0.05, compared with theWNK4
levels without KLHL3 coexpression [left lane] and with the mutant KLHL3 coexpression [right lane]; n = 3; mean ± SEM).
(D) Effect of the endogenous KLHL3 knockdown in mpkDCT cells on WNK4 expression. The protein levels of WNK4 were higher in KLHL3-knocked-down cells
than in control cells. siRNA, small interfering RNA.
(E) Effect of wild-type and a PHAII-causing mutant Cullin3 expression on the cellular abundance of WNK4. Although the expression of Cullin3 alone did not affect
WNK4 protein level, Cullin3 expression with KLHL3 dramatically reducedWNK4 protein. ThemutantCullin3 lacking the portion corresponding to exon 9 was less
able to reduce WNK4 protein. The existence of two bands in the immunoblot of Cullin3 was reported previously (McEvoy et al., 2007). Similar results were
obtained in three separate experiments.PHAII-Causing Mutations ofWNK4 and KLHL3 Affected
the Interaction of WNK4 and KLHL3 and the
Ubiquitination of WNK4
To investigate the mechanism(s) by which KLHL3 regulates the
WNK4 protein level, we examined the ubiquitination of wild-
type and PHAII-causing WNK4 with or without wild-type and
mutant KLHL3. In this assay, we did not overexpress Cullin3,
but used endogenous Cullin3 in HEK 293T cells (Figure 1C)
because the overexpression of Cullin3 with KLHL3 robustly
decreased WNK4 protein abundance (Figure 2E) under our
experimental conditions, even in the presence of proteasome
inhibitors, which made it difficult to recover WNK4 for immuno-
precipitation. After coexpression of FLAG-tagged WNK4, Halo-
tagged KLHL3, and hemagglutinin (HA)-tagged ubiquitin in
HEK293T cells, the cells were treated with 1 mM epoxomicin,860 Cell Reports 3, 858–868, March 28, 2013 ª2013 The Authorsand WNK4 was immunoprecipitated with FLAG antibody. First,
we evaluated whether KLHL3 expression increased WNK4
ubiquitination. For the exclusion of ubiquitination signals from
other proteins coimmunoprecipitated with WNK4, the immuno-
precipitation was performed under a denaturing condition (Fig-
ure 3A). As previously shown in Figures 2A and 2B, when we
expressed the wild-type KLHL3, the level of coexpressed wild-
type WNK4 decreased significantly, even in the presence of
a potent proteasome inhibitor (see WNK4 immunoblots of
lysates and immunoprecipitated products in Figures 3A and
3C). As shown in the ubiquitin (HA) immunoblot (Figure 3A), the
ubiquitination signals were observed as a smear band of over
200 kDa, which is the apparent molecular size of WNK4 (arrow).
This data strongly suggested that WNK4 itself was indeed ubiq-
uitinated, given that the immunoprecipitation was performed
under a denaturing condition. This ubiquitination was apparently
increased by KLHL3 coexpression when the ubiquitination
signals were corrected by the immunoprecipitated WNK4 abun-
dance. To make the difference clear without correction, we
adjusted the loading amount of the immunoprecipitated product
to have the same amount of immunoprecipitated WNK4 in each
lane in Figure 3A. A significant increase of WNK4 ubiquitination
by KLHL3 was observed.
To further confirm that WNK4 was directly ubiquitinated by the
KLHL3-Cullin3 complex, we performed an in vitro ubiquitination
assay. Because the preparation of whole WNK4 protein was not
successful, we prepared a portion of humanWNK4 protein (resi-
dues from 490 to 626) containing the PHAII mutation sites as
a GST fusion protein with a C-terminal His tag (50 kDa). As show-
n in the right panels of Figure 3A, we could confirm that the
KLHL3-Cullin3 complex was able to directly ubiquitinate WNK4
(490–626).
Second, we tested the effect of the R528H KLHL3mutation on
WNK4binding and ubiquitination. As already shown in Figure 2C,
coexpression of wild-type KLHL3 significantly reduced WNK4
expression as compared with the mutant KLHL3 (Figure 3B,
upper three panels). We observed a significant decrease in
WNK4 ubiquitination by the mutant KLHL3 and also the
decreased interaction of WNK4 with the mutant KLHL3 (Fig-
ure 3B, lower three panels).
We also tested the effect of PHAII-causing mutations ofWNK4
on WNK4-KLHL3 interaction and WNK4 ubiquitination. As
shown in Figure 3A, wild-type KLHL3 decreased WNK4.
However, this decrease mediated by KLHL3 was blunted in all
three PHAII-causing WNK4 mutants (Figure 3C, upper WNK4
panels). In the lower panels of Figure 3C, we showed the immno-
blots of coimunoprecitated KLHL3 and ubiquitinatedWNK4 after
the loading adjustment as shown in Figures 3A and 3B. At the
same time, we measured the signals before the loading adjust-
ment and corrected the levels of WNK4 abundance as shown
in Figure 3D. In either analysis, we could observe that the
WNK4 mutants appeared to show less interaction with wild-
type KLHL3 and less ubiquitination compared with wild-type
WNK4. An in vitro ubiquitination assay using the wild-type and
the mutant (D564A) WNK4 also supported this data (Figure S1).
The above data suggested that the acidic domain of WNK
kinases (Figure 4), where PHAII mutants were clustered in
WNK4, might be involved in the interaction with KLHL3. To
investigate this hypothesis and to clarify whether the interaction
of WNK4 and KLHL3 was direct, we measured the binding of
TAMRA-labeled WNK4 peptide covering the acidic motif to
the whole KLHL3 protein as a GST fusion protein in vitro. We
used fluorescence correlation spectroscopy (FCS) to measure
the diffusion time of the fluorescent peptide (FluoroPoint-Light,
Olympus, Tokyo) (Kuroki et al., 2007), in the presence of
different concentrations of GST-KLHL3. As shown in Figure 4,
the diffusion time of TAMRA-labeled peptide became slower
as the concentration of GST-KLHL3 increased, indicating that
the WNK4 peptide bound to GST- KLHL3. GST alone did not
affect the diffusion time, and the introduction of a PHAII-causing
mutation (D564A) abolished the decrease in diffusion time by
GST-KLHL3, clearly indicating that KLHL3 directly binds
to WNK4.WNK4Protein Level Increased in the PHAIIModelMouse
(Wnk4D561A/+) Kidney
To determine whether the mechanism clarified in the cell culture
studies was in fact working in the in vivo kidney, we re-evaluated
our PHAII model mice carrying the D561A WNK4 mutation,
which is equivalent to the human D564A mutation.
By using a recently generatedWNK4 antibody that recognizes
the amino terminus of WNK4 (Ohno et al., 2011), we found that
the WNK4 protein level was significantly increased in the
Wnk4D561A/+ mouse kidney (Figure 5A), which we missed in our
initial report (Yang et al., 2007). The specificity of this WNK4 anti-
body was rigorously verified (Ohno et al., 2011) and also recently
confirmed by using WNK4 knockout mice (Figure S2). Further-
more, the Wnk4D561A/D561A homozygous mouse showed
a more increased WNK4 protein level, suggesting that the muta-
tion may have a substantial effect in the regulation of the WNK4
protein level in vivo. We confirmed that the WNK4 messenger
RNA (mRNA) level was not increased in the Wnk4D561A/D561A
homozygous mouse kidney (Figure 5B), indicating that the
increase in the WNK4 protein level was not caused by transcrip-
tional activation.
Increased Expression of WNK4 in the Kidney Induced
the Activation of the WNK-OSR1/SPAK-NCC Signal
Cascade
To confirm whether the increased WNK4 protein level activates
OSR1/SPAK-NCC signaling in the kidney, we generated bacte-
rial artificial chromosome (BAC)-transgenic (TG) mice harboring
multiple copies of the wild-type WNK4 gene, as previously re-
ported (Lalioti et al., 2006). As shown in Figure 6A, we presented
the results of two representative transgenic lines; one had a low
copy number of the transgene (two copies) and the other had
a high copy number (thirty copies). WNK4 protein levels in the
kidneys of low copy number (LC) and high copy number (HC)
TG mice were increased 1.7 ± 0.1 (mean ± SEM)-fold in LC-TG
mice and 9.1 ± 0.2-fold in HC-TG mice (n = 5), compared with
those of wild-type mice. The phosphorylation of OSR1, SPAK,
and NCC in the kidney (Figure 6A) clearly increased as the
WNK4 protein levels increased in the TG mice. Immunofluores-
cence of phosphorylated NCC and WNK4 also clearly showed
the overexpression of WNK4 and the increased phosphorylation
of NCC in the distal convoluted tubules (Figure S3), confirming
the activation of WNK-OSR1/SPAK-NCC signaling in the TG
mice. Nighttime systolic, diastolic, and mean blood pressure
and daytime diastolic blood pressure were significantly
increased as the WNK4 protein levels increased in the TG mice
(Figure 6B). The blood pressure in these TG mice was also
comparable to that of Wnk4D561A/+ knockin mice measured by
the same telemetry system (wild-type versus Wnk4D561A/+
knockin: 118.3 ± 0.77 versus 125.1 ± 0.90, mean ±SEM, n = 4,
p < 0.05). The LC-TG and HC-TG mice also showed hyperkale-
mia and metabolic acidosis (Table 1) like Wnk4D561A/+ knockin
mice, and these phenotypes were more severe in HC-TG than
LC-TG mice. We also investigated the phosphorylation status
of NCC in two additional lines of transgene: one with no increase
in WNK4 protein with two copies of the transgene, suggesting
that the copy number of the transgene did not assure overex-
pression of the gene product, and the other with a robustCell Reports 3, 858–868, March 28, 2013 ª2013 The Authors 861
Figure 3. Effect of KLHL3 on the Ubiquitination of Wild-Type and PHAII-Causing Mutant WNK4
(A) Left panels: KLHL3 coexpression significantly induced the ubiquitination of wild-type WNK4. WNK4 was immunoprecipitated under a denaturing condition,
and ubiquitinated WNK4 was observed as a smear band over 200 kDa, which is the apparent molecular size of WNK4 (arrow). Coexpression of wild-type KLHL3
significantly reduced the wild-type WNK4 level, even in the presence of 1 mM epoxomicin. Accordingly, in the lower panels, we reloaded the immunoprecipitated
WNK4 samples to have equal amounts of immunoprecipitated WNK4 in each lane to demonstrate the difference in ubiquitination in each lane more clearly. We
confirmed in the preliminary experiments that the data after loading adjustment faithfully reflected the data corrected by the immunoprecipitated WNK4
abundance before adjustment.
Right panels: In vitro ubiquitination assay of WNK4. WNK4 (490–626; 50 kDa) was incubated with ubiquitin, E1, and E2 (UbcH5a/UBE2D1) with or without the
Cullin3-KLHL3 complex. Cullin3-KLHL3 significantly ubiquitinated WNK4 (490–626) in vitro. Similar results were obtained in three separate experiments.
(legend continued on next page)
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Figure 5. Increased WNK4 Protein Levels in Wnk4D561A/+ and
Wnk4D561A/D561A Knockin Mice
(A) WNK4 inWnk4D561A/+ andWnk4D561A/D561A mice was increased 2.2 ± 0.1-
and 2.7 ± 0.2-fold, respectively, compared with that in wild-type mice (n = 6,
mean ± SEM).
(B)WNK4 transcription was not increased in theWnk4D561A/D561A PHAII model
mouse. Quantitative RT-PCR revealed that WNK4 mRNA levels in Wnk4+/+
(open bar) and Wnk4D561A/D561A (closed bar) mouse kidneys were not statis-
tically different (mean ± SEM; n = 6; p = 0.34). n.s., not significant.
See also Figure S2.
Figure 4. Direct Binding of KLHL3 to the Acidic Motif of Wild-Type
WNK4
The diffusion time of a single-molecule TAMRA-labeled peptide corresponding
to the acidic domain of wild-typeWNK4wasmeasured by FCS. The addition of
GST-KLHL3, not of GST only, dose-dependently increased the diffusion
time, indicating the direct binding of KLHL3 to the acidic domain ofWNK4 (Kd =
0.20 mM). The diffusion time of a TAMRA-labeled peptide carrying a PHAII-
causingmutation (D564A) was not affected by the addition of GST-KLHL3. The
results are presented as means ± SEM (n = 5). N.D., not determined.increase in WNK4 protein with twenty copies of the transgene.
The increased phosphorylation of NCC was only observed in
the line with WNK4 overexpression (Figure S4). These results
clearly indicate that the activation of the WNK-OSR1/SPAK-
NCC cascade and the induction of PHAII phenotypes were
dependent on the increased WNK4 protein levels in the in vivo
kidney.(B) Effect of wild-type and a PHAII-causing mutant KLHL3 expression on WNK4-K
wild-type KLHL3 reduced the coexpressed WNK4 protein level more significa
Accordingly, as in Figure 3A, the immunoprecipitatedWNK4 samples were reload
The binding of WNK4 to mutant KLHL3 and WNK4 ubiquitination by the mutant
under a nondenaturing condition for assessing the binding to KLHL3 in the same
(C) Effect of PHAII-causing mutations of WNK4 on WNK4-KLHL3 binding and W
significantly reduced thewild-typeWNK4 level, even in the presence of 1 mMepox
(see WNK4 immunoblots of lysates or immunoprecipitates in the upper panels)
binding to KLHL3 (see quantification of blots in D).
(D) Quantification of the results showing the comparison of WNK4 ubiquitinatio
mutants. Upper graph, immunoprecipitated WNK4 abundance; middle graph,
WNK4 ubiquitination corrected by WNK4 abundance. WNK4 ubiquitination w
a denaturing condition. Data before loading adjustment were used for quantificat
compared with WT-WNK4 with KLHL3; n = 3; mean ± SEM).
See also Figure S1.DISCUSSION
We previously demonstrated the activation of the WNK-OSR1/
SPAK-NCC phosphorylation cascade in the mouse model of
PHAII, Wnk4D561A/+ knockin mice (Yang et al., 2007), by devel-
oping phosphospecific antibodies for residues of the amino-
terminal domain of NCC (Chiga et al., 2008; Yang et al., 2007).
Then, we and others clarified that this signal cascade was impor-
tant in blood pressure regulation under certain pathophysiolog-
ical conditions other than PHAII (Hoorn et al., 2011; Komers
et al., 2012; San-Cristobal et al., 2009; Sohara et al., 2011).
Thus, there is wide agreement (Gamba, 2012) that the phosphor-
ylation status of NCC governed by WNK-OSR1/SPAK signaling
reflects NCC activity in vivo. Given that PHAII is a thiazide-sensi-
tive disease, we speculated that KLHL3 and Cullin3 mutationsLHL3 binding and WNK4 ubiquitination. Upper panels: as shown in Figure 2C,
ntly than did the mutant KLHL3, even in the presence of 1 mM epoxomicin.
ed for equal amounts of immunoprecipitatedWNK4 in each lane (lower panels).
KLHL3 were significantly impaired. The immunoprecipitation was performed
experiments. Similar results were obtained in three separate experiments.
NK4 ubiquitination. As shown in Figure 3A, coexpression of wild-type KLHL3
omicin. However, this decrease was blunted in PHAII-causingWNK4mutations
. All three PHAII-causing WNK4 mutants showed less ubiquitination and less
n and WNK4 binding to KLHL3 among wild-type and PHAII-causing WNK4
coimmunoprecipitated KLHL3 corrected by WNK4 abundance; lower graph,
as evaluated by separate sets of immunoprecipitation experiments under
ion. (#p < 0.05 compared with wild-type [WT]-WNK4 without KLHL3; *p < 0.05
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Figure 6. Generation and Analysis ofWNK4 TG Mice
(A) Status of the WNK-OSR1/SPAK-NCC phosphorylation cascade in the
WNK4 TG mice (Tg(Wnk4WT)). WNK4 protein levels in the kidneys of LC (two
copies) and HC (thirty copies) TGmice were increased 1.7 ± 0.1- and 9.1 ± 0.2-
fold, respectively (*p < 0.05, n = 5, mean ± SEM). NCC phosphorylation in
these mice was significantly increased, compared with that of wild-type mice
(p < 0.05, n = 5, mean ± SEM). The phosphorylation of SPAK in LC-TG and HC-
TG mice and that of OSR1 in HC-TG mice was also significantly increased
compared to that of wild-typemice (p < 0.05, n = 5, mean ±SEM). The total and
phosphorylated OSR1, SPAK, and NCC in HC-TG mice were significantly
increased compared with those in LC-TG mice (p < 0.05, n = 5, mean ± SEM).
(B) Nighttime systolic, diastolic, and mean blood pressure (BP) and daytime
diastolic blood pressure were significantly increased as the WNK4 protein
levels increased in the Tg(Wnk4WT) mice. Values were collected over 7
consecutive days (daytime: from 8:00 until 20:00; nighttime: from 20:00 until
8:00). *p < 0.05 versusWT; yp < 0.05 versus LC; WT n = 5; LC-TG n = 5; HC-TG
n = 4; mean ± SEM.
See also Figures S3 and S4.
Table 1. Blood Biochemistries ofWT and LC- and HC-Tg(Wnk4WT)
Mice
WT Mice
(n = 16)
LC (n = 16)
Tg(Wnk4WT) Mice
HC (n = 16)
Tg(Wnk4WT) Mice
Na (mmol/l) 145.4 ± 0.3 147.0 ± 0.3* 147.4 ± 0.5**
K (mmol/l) 4.2 ± 0.1 5.1 ± 0.1** 5.5 ± 0.1**,y
Cl (mmol/l) 110.3 ± 0.3 111.9 ± 0.3** 112.8 ± 0.5**
HCO3
 (mmol/l) 24.4 ± 0.3 21.5 ± 0.4** 21.1 ± 0.3**
pH (venous) 7.302 ± 0.023 7.245 ± 0.003** 7.220 ± 0.004**,yy
Values are the mean ± SEM. *, p < 0.05; **, p < 0.01 versus wild-type (WT)
(one-way ANOVA followed by Tukey’s post hoc test). y, p < 0.05; yy,
p < 0.01 versus low copy number (one-way ANOVA followed by Tukey’s
test). Low copy number (LC) and high copy number (HC) Tg(Wnk4WT)
mice showed hyperkalemia and metabolic acidosis.would also activate the WNK-OSR1/SPAK-NCC phosphoryla-
tion cascade. Gamba’s group also recently clarified that the
major WNK kinase regulating NCC phosphorylation in the kidney864 Cell Reports 3, 858–868, March 28, 2013 ª2013 The Authorsis WNK4 (Castan˜eda-Bueno et al., 2012). Accordingly, we first
performed coimmunoprecipitation assays of KLHL3 with the
components of the WNK4-OSR1/SPAK-NCC cascade because
KLHL proteins have been recently identified as substrate adap-
tors in the Cullin3-based ubiquitin E3 ligase (Cirak et al., 2010;
Kigoshi et al., 2011; Lee et al., 2010; Lin et al., 2011).
We found that KLHL3 showed a clear interaction only with
WNK4 among the components of the cascade. The direct
binding of WNK4 to KLHL3 at the acidic motif was also
confirmed in this study. In addition to the interaction, we showed
that KLHL3 coexpression dramatically reduced both overex-
pressed and endogenous WNK4, indicating that KLHL3 is
a strong regulator of WNK4 protein abundance within cells.
Such an effect was reduced in the PHAII-causing mutations of
WNK4 and KLHL3, resulting in a common consequence: the
increase in WNK4 protein abundance. We also confirmed that
the interaction of KLHL3 with WNK4 induced the ubiquitination
of WNK4 in HEK293T cells and in in vitro ubiquitination assay.
The reduced interaction of KLHL3 with WNK4 by PHAII-causing
mutations in either protein also reduced the ubiquitination of
WNK4, and the PHAII-causing mutant Cullin3 was less able to
reduce WNK4 protein abundance. Although we cannot exclude
the possibility that KLHL3 may have targets other than WNK4,
these results strongly suggest that WNK4 protein abundance
within cells is regulated by KLHL3-Cullin3-mediated ubiquitina-
tion of WNK4 and that the major common molecular mechanism
of PHAII is the impaired ubiquitination of WNK4.
Because the in vitro data could explain the molecular patho-
genesis of PHAII caused by three different kinds of molecules,
i.e., WNK4, KLHL3, and Cullin3, we verified this idea in vivo.
Previously, WNK4 was shown to be able to phosphorylate and
activate OSR1 and SPAK, as well as WNK1, in vitro (Moriguchi
et al., 2005), and Ahlstrom and Yu (2009) reported in HEK293
cells that the intrinsic kinase activity of PHAII-causing mutant
WNK4 was not different from that of wild-type WNK4. Given
that the recent data onWNK4 knockout mice (Castan˜eda-Bueno
et al., 2012) clearly indicate that WNK4 is the major WNK kinase
in the kidney, we think it is reasonable to infer that the increased
WNK4 abundance in the kidney, as we observed in the
Wnk4D561A/+ mice, could activate the cascade and was the
cause of PHAII. To further prove this idea, we generated wild-
typeWNK4-TG mice as previously reported (Lalioti et al., 2006).
We evaluated several lines of TG mice with different levels of
WNK4 protein overexpression, and we think that WNK4 TG
mice could mimic Wnk4D561A/+ knockin mice. We clearly
showed that the WNK-OSR1/SPAK-NCC cascade and the
PHAII phenotypes were induced according to the increases in
wild-type WNK4 protein overexpression. This WNK4-dependent
expression of phenotypes strongly suggests that these pheno-
types were not caused by a nonspecific effect of the transgene.
Several studies, mainly performed in Xenopus oocytes and in
cultured cells, have shown that WNK4 behaves as a negative
regulator of NCC (Wilson et al., 2003; Yang et al., 2003). This
negative effect was shown to be a kinase-activity-independent
function of WNK4 (Yang et al., 2005), suggesting that the
kinase-activity-dependent positive and -activity-independent
negative effects of WNK4 might act on NCC concomitantly
and that the net effect might differ in different experimental situ-
ations. In fact, the WNK4-TG mouse with the wild-type WNK4
gene generated by Lalioti et al. (2006) was reported to show Gi-
telman-syndrome-like phenotypes rather than those of PHAII,
which is contrary to our TG data in this study. No data regarding
the status of the WNK-OSR1/SPAK-NCC cascade and WNK4
protein level in their TG mice have been reported (Lalioti et al.,
2006). In addition, it was not clear whether the negative effect
of wild-type WNK4 on NCC was dependent on WNK4 protein
levels, because only a single line of TG mice was reported.
Therefore, the reason for the discrepancy between our WNK4
TG study and Lalioti’s study is not clear. It is possible that the
level of WNK4 protein in their TG mice might be less than those
in our WNK4 TG mice and PHAII models (about 2-fold
increases); they mentioned that only a 50% increase in WNK4
mRNA expression was observed in their TG mice. The net effect
of WNK4 on NCCmight be expressed as a negative effect under
such conditions. Our previous study using the triple knockin
mice of WNK4, OSR1, and SPAK suggested that the contribu-
tion of this negative effect of WNK4 on NCC might be minimal
in the kidney, at least under PHAII conditions (Chiga et al.,
2011). Our TG data in this study also clearly indicate that the
increase in WNK4 protein at the PHAII level or higher brought
about a positive net effect on NCC.
Because NCC phosphorylation in the kidney is highly depen-
dent on WNK4 (Castan˜eda-Bueno et al., 2012; Oi et al., 2012;
Susa et al., 2012), we focused on WNK4 in this study. However,
WNK kinases other than WNK4 may also be regulated by the
KLHL3-Cullin3 complex. The amino acid sequence of the
KLHL3 binding site in WNK4 is highly conserved in other WNK
kinases (Figure 4), and we could observe that WNK1 protein,
as well as WNK4 protein, was decreased by overexpression
and increased by knockdown of KLHL3 (Figure S5). In this
respect,WNK1 aswell asWNK4may be increased in the kidneys
of patients with PHAII carrying the KLHL3 and Cullin3mutations,
thereby contributing to the activation of OSR1/SPAK-NCC
signaling and to more severe PHAII phenotypes via Cullin3 and
KLHL3 than those via WNK1 and WNK4 (Boyden et al., 2012).
Because the PHAII-causing mutations of WNK1 are the large
deletions of intron 1, which reportedly increases WNK1 tran-
scription (Wilson et al., 2001), the mechanism clarified in this
study may not be directly related to the pathogenesis of PHAIIby the WNK1 mutations. However, we may consider PHAII as
a disease caused by increased WNK kinase abundance either
by the dysregulation of transcription or by the ubiquitination of
WNK kinases.
In summary, our study identified that WNK4 is a substrate of
KLHL3-Cullin3-mediated ubiquitination and that the impaired
ubiquitination of WNK4 is a common mechanism of PHAII by
WNK4, KLHL3, and Cullin3 PHAII-causing mutations. Additional
studies may be necessary to confirm this pathogenic mecha-
nism in vivo by generating KLHL3 and Cullin3 knockin mice
carrying PHAII mutations.
EXPERIMENTAL PROCEDURES
Plasmids
Expression plasmids for 33FLAG-tagged human WNK4 and 33FLAG-tagged
D564A human WNK4 have been described previously (Yamauchi et al., 2004).
E562K and Q565E mutations were also introduced by using a QuikChange
Site-Directed Mutagenesis Kit (Stratagene). The complementary DNA
(cDNA) encoding Halo-tagged human KLHL3 in pFN21A vector (HT-KLHL3)
was purchased from Promega, and a disease-causing mutation (R528H)
was introduced. Human Cullin3 cDNA was isolated by RT-PCR using human
prostate mRNA as a template, and the cDNA was cloned into 33FLAG-
CMV10 vector (Sigma-Aldrich). T7-tagged OSR1, T7-tagged SPAK, and
T7-tagged NCC expression plasmids in pRK5 vector were kindly provided
by T. Moriguchi and H. Shibuya (Moriguchi et al., 2005). T7-tagged human
WNK4 construct was also generated by introducing the T7 epitope by PCR.
HA4-tagged ubiquitin expression vector was kindly provided by T. Ohta (St.
Marianna University School of Medicine).
Cell Culture and Transfections
HEK293T cells were cultured in Dulbecco’s modified Eagle’s medium supple-
mented with 10% (v/v) fetal bovine serum, 2 mM L-glutamine, 100 U/ml
penicillin, and 0.1 mg/ml streptomycin at 37C in a humidified 5% CO2 incu-
bator. The mpkDCT cell line kindly provided by A. Vandewalle was cultured
in a defined medium as described previously (Duong Van Huyen et al.,
2001). HEK293T cells and mpkDCT cells (3 3 105 cells per 6 cm dish) were
transfected by the indicated amount of plasmid DNA with Lipofectamine
2000 reagent (Invitrogen). For each transfection, 48 mg of expression vectors
were used, and the total amount of plasmid DNA was adjusted by adding
empty vectors. In preliminary experiments, FLAG-tagged BAP (Figure 2A)
was used for evaluating the transfection efficiency of transient expression of
FLAG-tagged WNK4.
Immunoprecipitation
HEK293T cells transfected with the indicated amount of DNA were lysed in
a buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% Nonidet P-40, 1 mM
sodium orthovanadate, 50 mM sodium fluoride, and protease inhibitor cock-
tail) for 30 min at 4C. When the cells were transfected with the HA-ubiquitin
expression plasmid, the cells were treated with 1 mM epoxomicin (specific
and irreversible proteasome inhibitor; Peptide Institute, Osaka, Japan) for
3 hr before harvesting. After centrifugation at 12,0003 g for 15min, the protein
concentration of the supernatants was measured, and equal amounts of the
supernatants were used for immunoprecipitation with anti-FLAG M2 beads
(Sigma-Aldrich) or anti-T7 beads (Merck Millipore) for 2 hr at 4C. Thereafter,
the precipitants were washed with the lysis buffer and the immunoprecipitates
were eluted in SDS sample buffer after boiling for 5 min. To detect ubiquitina-
tion of WNK4 in denatured samples, the cells transfected with various plas-
mids were lysed in 2% SDS buffer (2% SDS, 150 mM NaCl, 10 mM Tris-HCl
[pH 8.0], 2 mM sodium orthovanadate, 50 mM sodium fluoride, and 13
protease inhibitors) and boiled for 10 min, followed by sonication. Before
immunoprecipitation, the lysates were diluted 1:10 in a dilution buffer
(10 mM Tris-HCl [pH 8.0], 150 mM NaCl, 2 mM EDTA, and 1% Triton X-100),
incubated at 4C for 1 hr with rotation, and centrifuged at 12,000 3 g for
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Immunoblotting
Whole homogenates of mouse kidney without the nuclear fraction (600 3 g)
or the crude membrane fraction (17,000 3 g) were subjected to semiquanti-
tative immunoblotting, as described previously (Yang et al., 2007). Cells
transfected with the indicated amount of plasmid DNA were lysed in lysis
buffer (50 mM Tris-HCl [pH 7.5], 150 mM NaCl, 1% Nonidet P-40, 1 mM
sodium orthovanadate, 50 mM sodium fluoride, and protease inhibitor cock-
tail [Roche Diagnostics]) for 30 min at 4C. After centrifugation at 12,000 3 g
for 15 min, the supernatants were boiled with SDS sample buffer (Cosmo
Bio USA) and subjected to SDS-PAGE. Blots were probed with the following
primary antibodies: anti-total NCC (Ohno et al., 2011), anti-phosphorylated
NCC (pSer71) (Yang et al., 2007), anti-WNK4 (Ohno et al., 2011; Ohta
et al., 2009), anti-total OSR1 (M9; Abnova), anti-phosphorylated OSR1
(Ohta et al., 2009), anti-total SPAK (Cell Signaling Technology), anti-phos-
phorylated SPAK (Yang et al., 2010), anti-GAPDH (Santa Cruz Biotech-
nology), anti-actin (Cytoskeleton), anti-HA (Merck Millipore), anti-KLHL3
(Abcam), anti-Cullin3 (Abcam), anti-FLAG (Sigma-Aldrich), anti-Halo (Prom-
ega), and anti-T7 (Merck Millipore). Specificities of anti-pNCC, pOSR1, and
pSPAK were rigorously determined in our previous reports (Chiga et al.,
2008; Ohta et al., 2009; Yang et al., 2007, 2010). Alkaline-phosphatase-
conjugated immunoglobulin G antibodies (Promega) were used as
secondary antibodies for immunoblotting. The intensity of the bands was
analyzed and quantified by using ImageJ software (National Institutes of
Health).
In Vitro Ubiquitination Assay
cDNA encoding human WNK4 (490–626) with a C-terminal His-tag was ampli-
fied by PCR and cloned into pGEX6p-1 vector. Recombinant GST fusion
WNK4 protein was expressed in BL21 E. coli cells and purified by using
glutathione sepharose beads. KLHL3-Cullin3 complexes were immunoprecip-
itated from the lysates of HEK293T cells transiently expressing FLAG-Cullin3
and Halo-KLHL3. Then, the complexes were incubated in 20 ml of reaction
buffer (50 mM Tris-HCl [pH 7.4], 2.5 mM MgCl2, 0.5 mM DTT, and 2 mM
ATP) for 2 hr at 30C with purified GST-WNK4-His (5 mg), 100 ng recombinant
human E1 (Boston Biochem), 500 ng recombinant human UbcH5a/UBE2D1
(Boston Biochem), and 2.5 mg recombinant human ubiquitin (Boston
Biochem). The reaction was terminated by the addition of SDS-PAGE sample
buffer, followed by boiling for 5min. The reactionmixtures were then subjected
to immunoblot analyses with ubiquitin (Cell Signaling Technology) or His
(Abcam) antibodies.
Quantitative RT-PCR
6.1441mmBoth kidneys were removed, immediately frozen in dry ice, and
fragmented and homogenized in TRIzol Reagent (Invitrogen). Isolated
total RNA was reverse-transcribed by using Omniscript reverse tran-
scriptase (QIAGEN), and quantitative real-time PCR analysis was performed
in triplicate by using SYBR Green I (Roche Applied Science) on LightCycler
2.0 (Roche). Amplification primers forWNK4 were the same as reported previ-
ously (O’Reilly et al., 2006), and the primers for GAPDH were purchased from
Roche Diagnostics. WNK4 mRNA levels were corrected by GAPDH mRNA
levels.
Fluorescence Correlation Spectroscopy
Fluorescent TAMRA-labeled WNK4 peptides covering the PHAII mutation
sites were prepared (Hokkaido System Science, Hokkaido, Japan). The
sequence details of the peptides are shown in Figure 4. Human full-length
KLHL3 was cloned into pGEX6P-1 vector. Recombinant GST fusion KLHL3
protein was expressed in BL21 E. coli cells and purified by using glutathione
sepharose beads. The TAMRA-labeled WNK4 peptides were incubated at
room temperature for 30 min with different concentrations of GST-KLHL3
(0–2 mM) in 1 3 PBS with 0.05% Tween 20 reaction buffer, and the FCS
measurements of single-molecule fluorescence were performed using the
FluoroPoint-Light analytical system (Olympus) (Kuroki et al., 2007). The assay
was performed in a 384-well plate. All experiments were performed in 10 s of
data-acquisition time, and the measurements were repeated five times per
sample.866 Cell Reports 3, 858–868, March 28, 2013 ª2013 The AuthorsProduction ofWnk4 BAC TG Mice
The BAC clone bMQ428o09, which contains the mouse genomic Wnk4
locus, was used. For Southern blot analysis and PCR genotyping, a new
SpeI site was created in intron 6 of the Wnk4 genomic locus. The BAC modi-
fication was performed as previously described (Warming et al., 2005). Purified
BAC DNA was then digested with SwaI, and the desired 36.8 kb fragment was
isolated after fractionation via inverted pulse field gel electrophoresis, as re-
ported previously (Lalioti et al., 2006). The purified fragment was injected
into one-cell embryos of C57BL/6J mice. The copy number of the transgene
was estimated by Southern blotting and quantitative PCR. The Animal Care
and Use Committee of Tokyo Medical and Dental University approved this
experiment (0120038B).
Blood Pressure Measurements
We measured blood pressure by using a radiotelemetric method (Mills et al.,
2000) in which a blood pressure transducer (Data Sciences International, St.
Paul, MN, USA) was inserted into the left carotid artery. Seven days after trans-
plantation, each mouse was housed individually in a standard cage on
a receiver under a 12 hr light-dark cycle. Systolic and diastolic blood pressure,
heart rate, and activity were recorded every minute via radiotelemetry. Mice
showed alternating periods of high activity (20:00–8:00) and low activity
(8:00–20:00). For each mouse, we measured blood pressure values for more
than 5 consecutive days and calculated the mean ± SEM of all values during
both the high- and low-activity periods.
Blood Data Analyses
Blood for electrolyte analyses was obtained as described previously (Yang
et al., 2007). Electrolyte levels were determined with an i-STAT analyzer
(Fuso Pharmaceutical Industries, Osaka, Japan).
Statistical Analysis
Comparisons between the two groups were performed with unpaired t tests.
ANOVAwith Tukey’s post hoc test was used to evaluate statistical significance
in the comparison among multiple groups. p values <0.05 were considered
statistically significant. Data are presented as the mean ± SEM.
SUPPLEMENTAL INFORMATION
Supplemental Information includes five figures and can be found with this
article online at http://dx.doi.org/10.1016/j.celrep.2013.02.024.
LICENSING INFORMATION
This is an open-access article distributed under the terms of the Creative
Commons Attribution-NonCommercial-No Derivative Works License, which
permits non-commercial use, distribution, and reproduction in any medium,
provided the original author and source are credited.
ACKNOWLEDGMENTS
This study was supported in part by Grants-in-Aid for Scientific Research (A)
from the Japan Society for the Promotion of Science; a Health and Labor
Sciences Research Grant from the Ministry of Health, Labor, and Welfare;
the Salt Science Research Foundation (grant no. 1026, 1228); the Takeda
Science Foundation; and a Banyu Foundation Research Grant.
Received: November 28, 2012
Revised: January 25, 2013
Accepted: February 13, 2013
Published: February 28, 2013
REFERENCES
Achard, J.M., Disse-Nicodeme, S., Fiquet-Kempf, B., and Jeunemaitre, X.
(2001). Phenotypic and genetic heterogeneity of familial hyperkalaemic hyper-
tension (Gordon syndrome). Clin. Exp. Pharmacol. Physiol. 28, 1048–1052.
Ahlstrom, R., and Yu, A.S. (2009). Characterization of the kinase activity of
a WNK4 protein complex. Am. J. Physiol. Renal Physiol. 297, F685–F692.
Bergaya, S., Faure, S., Baudrie, V., Rio, M., Escoubet, B., Bonnin, P., Henrion,
D., Loirand, G., Achard, J.M., Jeunemaitre, X., and Hadchouel, J. (2011).
WNK1 regulates vasoconstriction and blood pressure response to a 1-adren-
ergic stimulation in mice. Hypertension 58, 439–445.
Boyden, L.M., Choi, M., Choate, K.A., Nelson-Williams, C.J., Farhi, A., Toka,
H.R., Tikhonova, I.R., Bjornson, R.,Mane, S.M., Colussi, G., et al. (2012). Muta-
tions in kelch-like 3 and cullin 3 cause hypertension and electrolyte abnormal-
ities. Nature 482, 98–102.
Castan˜eda-Bueno, M., Cervantes-Pe´rez, L.G., Va´zquez, N., Uribe, N.,
Kantesaria, S., Morla, L., Bobadilla, N.A., Doucet, A., Alessi, D.R., and
Gamba, G. (2012). Activation of the renal Na+:Cl- cotransporter by angio-
tensin II is a WNK4-dependent process. Proc. Natl. Acad. Sci. USA 109,
7929–7934.
Chiga, M., Rai, T., Yang, S.S., Ohta, A., Takizawa, T., Sasaki, S., andUchida, S.
(2008). Dietary salt regulates the phosphorylation of OSR1/SPAK kinases
and the sodium chloride cotransporter through aldosterone. Kidney Int. 74,
1403–1409.
Chiga, M., Rafiqi, F.H., Alessi, D.R., Sohara, E., Ohta, A., Rai, T., Sasaki, S.,
and Uchida, S. (2011). Phenotypes of pseudohypoaldosteronism type II
caused by the WNK4 D561A missense mutation are dependent on the
WNK-OSR1/SPAK kinase cascade. J. Cell Sci. 124, 1391–1395.
Cirak, S., von Deimling, F., Sachdev, S., Errington, W.J., Herrmann, R., Bo¨nne-
mann, C., Brockmann, K., Hinderlich, S., Lindner, T.H., Steinbrecher, A., et al.
(2010). Kelch-like homologue 9 mutation is associated with an early onset
autosomal dominant distal myopathy. Brain 133, 2123–2135.
Duong Van Huyen, J.P., Bens, M., Teulon, J., and Vandewalle, A. (2001).
Vasopressin-stimulated chloride transport in transimmortalized mouse cell
lines derived from the distal convoluted tubule and cortical and inner medullary
collecting ducts. Nephrol. Dial. Transplant. 16, 238–245.
Gamba, G. (2012). Regulation of the renal Na+-Cl- cotransporter by phosphor-
ylation and ubiquitylation. Am. J. Physiol. Renal Physiol. 303, F1573–F1583.
Gordon, R.D. (1986). Syndrome of hypertension and hyperkalemia with normal
glomerular filtration rate. Hypertension 8, 93–102.
Hoorn, E.J., Walsh, S.B., McCormick, J.A., Fu¨rstenberg, A., Yang, C.L.,
Roeschel, T., Paliege, A., Howie, A.J., Conley, J., Bachmann, S., et al.
(2011). The calcineurin inhibitor tacrolimus activates the renal sodium chloride
cotransporter to cause hypertension. Nat. Med. 17, 1304–1309.
Kigoshi, Y., Tsuruta, F., and Chiba, T. (2011). Ubiquitin ligase activity of Cul3-
KLHL7 protein is attenuated by autosomal dominant retinitis pigmentosa
causative mutation. J. Biol. Chem. 286, 33613–33621.
Komers, R., Rogers, S., Oyama, T.T., Xu, B., Yang, C.L., McCormick, J., and
Ellison, D.H. (2012). Enhanced phosphorylation of Na(+)-Cl- co-transporter in
experimental metabolic syndrome: role of insulin. Clin. Sci. 123, 635–647.
Kuroki, K., Kobayashi, S., Shiroishi, M., Kajikawa, M., Okamoto, N., Kohda, D.,
and Maenaka, K. (2007). Detection of weak ligand interactions of leukocyte
Ig-like receptor B1 by fluorescence correlation spectroscopy. J. Immunol.
Methods 320, 172–176.
Lalioti, M.D., Zhang, J., Volkman, H.M., Kahle, K.T., Hoffmann, K.E., Toka,
H.R., Nelson-Williams, C., Ellison, D.H., Flavell, R., Booth, C.J., et al.
(2006). Wnk4 controls blood pressure and potassium homeostasis via regu-
lation of mass and activity of the distal convoluted tubule. Nat. Genet. 38,
1124–1132.
Lee, Y.R., Yuan, W.C., Ho, H.C., Chen, C.H., Shih, H.M., and Chen, R.H.
(2010). The Cullin 3 substrate adaptor KLHL20 mediates DAPK ubiquitination
to control interferon responses. EMBO J. 29, 1748–1761.
Lin, M.Y., Lin, Y.M., Kao, T.C., Chuang, H.H., and Chen, R.H. (2011). PDZ-
RhoGEF ubiquitination by Cullin3-KLHL20 controls neurotrophin-induced
neurite outgrowth. J. Cell Biol. 193, 985–994.
Liu, Z., Xie, J., Wu, T., Truong, T., Auchus, R.J., and Huang, C.L. (2011). Down-
regulation of NCC and NKCC2 cotransporters by kidney-specific WNK1 re-vealed by gene disruption and transgenic mouse models. Hum. Mol. Genet.
20, 855–866.
Louis-Dit-Picard, H., Barc, J., Trujillano, D., Miserey-Lenkei, S., Bouatia-Naji,
N., Pylypenko, O., Beaurain, G., Bonnefond, A., Sand, O., Simian, C., et al.;
International Consortium for Blood Pressure (ICBP). (2012). KLHL3 mutations
cause familial hyperkalemic hypertension by impairing ion transport in the
distal nephron. Nat. Genet. 44, 456–460, S1–S3.
McCormick, J.A., and Ellison, D.H. (2011). The WNKs: atypical protein kinases
with pleiotropic actions. Physiol. Rev. 91, 177–219.
McEvoy, J.D., Kossatz, U., Malek, N., and Singer, J.D. (2007). Constitutive
turnover of cyclin E by Cul3 maintains quiescence. Mol. Cell. Biol. 27, 3651–
3666.
Mills, P.A., Huetteman, D.A., Brockway, B.P., Zwiers, L.M., Gelsema, A.J.,
Schwartz, R.S., and Kramer, K. (2000). A new method for measurement of
blood pressure, heart rate, and activity in the mouse by radiotelemetry. J.
Appl. Physiol. 88, 1537–1544.
Moriguchi, T., Urushiyama, S., Hisamoto, N., Iemura, S., Uchida, S., Natsume,
T., Matsumoto, K., and Shibuya, H. (2005). WNK1 regulates phosphorylation of
cation-chloride-coupled cotransporters via the STE20-related kinases, SPAK
and OSR1. J. Biol. Chem. 280, 42685–42693.
O’Reilly, M., Marshall, E., Macgillivray, T., Mittal, M., Xue, W., Kenyon, C.J.,
and Brown, R.W. (2006). Dietary electrolyte-driven responses in the renal
WNK kinase pathway in vivo. J. Am. Soc. Nephrol. 17, 2402–2413.
Ohno, M., Uchida, K., Ohashi, T., Nitta, K., Ohta, A., Chiga, M., Sasaki, S., and
Uchida, S. (2011). Immunolocalization of WNK4 in mouse kidney. Histochem.
Cell Biol. 136, 25–35.
Ohta, A., Rai, T., Yui, N., Chiga, M., Yang, S.S., Lin, S.H., Sohara, E., Sasaki, S.,
and Uchida, S. (2009). Targeted disruption of the Wnk4 gene decreases phos-
phorylation of Na-Cl cotransporter, increases Na excretion and lowers blood
pressure. Hum. Mol. Genet. 18, 3978–3986.
Oi, K., Sohara, E., Rai, T., Misawa, M., Chiga, M., Alessi, D.R., Sasaki, S., and
Uchida, S. (2012). A minor role of WNK3 in regulating phosphorylation of renal
NKCC2 and NCC co-transporters in vivo. Biol. Open 1, 120–127.
Rossier, B.C., and Schild, L. (2008). Epithelial sodium channel: mendelian
versus essential hypertension. Hypertension 52, 595–600.
San-Cristobal, P., Pacheco-Alvarez, D., Richardson, C., Ring, A.M., Vazquez,
N., Rafiqi, F.H., Chari, D., Kahle, K.T., Leng, Q., Bobadilla, N.A., et al. (2009).
Angiotensin II signaling increases activity of the renal Na-Cl cotransporter
through a WNK4-SPAK-dependent pathway. Proc. Natl. Acad. Sci. USA
106, 4384–4389.
Shimkets, R.A., Warnock, D.G., Bositis, C.M., Nelson-Williams, C., Hansson,
J.H., Schambelan, M., Gill, J.R., Jr., Ulick, S., Milora, R.V., Findling, J.W.,
et al. (1994). Liddle’s syndrome: heritable human hypertension caused
by mutations in the beta subunit of the epithelial sodium channel. Cell 79,
407–414.
Sohara, E., Rai, T., Yang, S.S., Ohta, A., Naito, S., Chiga, M., Nomura, N., Lin,
S.H., Vandewalle, A., Ohta, E., et al. (2011). Acute insulin stimulation induces
phosphorylation of the Na-Cl cotransporter in cultured distal mpkDCT cells
and mouse kidney. PLoS ONE 6, e24277.
Susa, K., Kita, S., Iwamoto, T., Yang, S.S., Lin, S.H., Ohta, A., Sohara, E.,
Rai, T., Sasaki, S., Alessi, D.R., and Uchida, S. (2012). Effect of
heterozygous deletion of WNK1 on the WNK-OSR1/ SPAK-NCC/NKCC1/
NKCC2 signal cascade in the kidney and blood vessels. Clin. Exp. Nephrol.
16, 530–538.
Warming, S., Costantino, N., Court, D.L., Jenkins, N.A., and Copeland, N.G.
(2005). Simple and highly efficient BAC recombineering using galK selection.
Nucleic Acids Res. 33, e36.
Wilson, F.H., Disse-Nicode`me, S., Choate, K.A., Ishikawa, K., Nelson-Wil-
liams, C., Desitter, I., Gunel, M., Milford, D.V., Lipkin, G.W., Achard, J.M.,
et al. (2001). Human hypertension caused by mutations in WNK kinases.
Science 293, 1107–1112.
Wilson, F.H., Kahle, K.T., Sabath, E., Lalioti, M.D., Rapson, A.K., Hoover,
R.S., Hebert, S.C., Gamba, G., and Lifton, R.P. (2003). MolecularCell Reports 3, 858–868, March 28, 2013 ª2013 The Authors 867
pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotrans-
porter is inhibited by wild-type but not mutant WNK4. Proc. Natl. Acad. Sci.
USA 100, 680–684.
Yamauchi, K., Rai, T., Kobayashi, K., Sohara, E., Suzuki, T., Itoh, T., Suda, S.,
Hayama, A., Sasaki, S., and Uchida, S. (2004). Disease-causing mutant WNK4
increases paracellular chloride permeability and phosphorylates claudins.
Proc. Natl. Acad. Sci. USA 101, 4690–4694.
Yang, C.L., Angell, J., Mitchell, R., and Ellison, D.H. (2003). WNK
kinases regulate thiazide-sensitive Na-Cl cotransport. J. Clin. Invest. 111,
1039–1045.868 Cell Reports 3, 858–868, March 28, 2013 ª2013 The AuthorsYang, C.L., Zhu, X., Wang, Z., Subramanya, A.R., and Ellison, D.H. (2005).
Mechanisms of WNK1 and WNK4 interaction in the regulation of thiazide-
sensitive NaCl cotransport. J. Clin. Invest. 115, 1379–1387.
Yang, S.S., Morimoto, T., Rai, T., Chiga, M., Sohara, E., Ohno, M., Uchida, K.,
Lin, S.H., Moriguchi, T., Shibuya, H., et al. (2007). Molecular pathogenesis
of pseudohypoaldosteronism type II: generation and analysis of a
Wnk4(D561A/+) knockin mouse model. Cell Metab. 5, 331–344.
Yang, S.S., Lo, Y.F., Wu, C.C., Lin, S.W., Yeh, C.J., Chu, P., Sytwu, H.K.,
Uchida, S., Sasaki, S., and Lin, S.H. (2010). SPAK-knockout mice manifest
Gitelman syndrome and impaired vasoconstriction. J. Am. Soc. Nephrol. 21,
1868–1877.
